Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system

Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Orthop Res
Asıl Yazarlar: Feng, Yong, Sassi, Slim, Shen, Jacson K, Yang, Xiaoqian, Gao, Yan, Osaka, Eiji, Zhang, Jianming, Yang, Shuhua, Yang, Cao, Mankin, Henry J., Hornicek, Francis J, Duan, Zhenfeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/
https://ncbi.nlm.nih.gov/pubmed/25348612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller